Background: Despite multiple reports of chemotherapy overdoses (ODs) in human and veterinary medicine, anthracycline ODs have been described infrequently.
Hypothesis/objectives: Describe toxicities, treatments, and overall outcome after anthracycline OD in dogs.
Animals: Twelve mitoxantrone (MTX) and 4 doxorubicin (DOX) ODs were evaluated.